Global TB Vaccine Treatment Market Research Report 2023
TB Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
According to QYResearch’s new survey, global TB Vaccine Treatment market is projected to reach US$ 88 million in 2029, increasing from US$ 72 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole TB Vaccine Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global TB Vaccine Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global TB Vaccine Treatment market is projected to reach US$ 88 million in 2029, increasing from US$ 72 million in 2022, with the CAGR of 2.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole TB Vaccine Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global TB Vaccine Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 TB VACCINE TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of TB Vaccine Treatment
1.2 TB Vaccine Treatment Segment by Type
1.2.1 Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 TB Vaccine Treatment Segment by Application
1.3.1 Global TB Vaccine Treatment Market Value by Application: (2023-2029)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global TB Vaccine Treatment Market Size Estimates and Forecasts
1.4.1 Global TB Vaccine Treatment Revenue 2018-2029
1.4.2 Global TB Vaccine Treatment Sales 2018-2029
1.4.3 Global TB Vaccine Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 TB VACCINE TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global TB Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global TB Vaccine Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global TB Vaccine Treatment Average Price by Manufacturers (2018-2023)
2.4 Global TB Vaccine Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
2.7 TB Vaccine Treatment Market Competitive Situation and Trends
2.7.1 TB Vaccine Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest TB Vaccine Treatment Players Market Share by Revenue
2.7.3 Global TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TB VACCINE TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global TB Vaccine Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global TB Vaccine Treatment Global TB Vaccine Treatment Sales by Region: 2018-2029
3.2.1 Global TB Vaccine Treatment Sales by Region: 2018-2023
3.2.2 Global TB Vaccine Treatment Sales by Region: 2024-2029
3.3 Global TB Vaccine Treatment Global TB Vaccine Treatment Revenue by Region: 2018-2029
3.3.1 Global TB Vaccine Treatment Revenue by Region: 2018-2023
3.3.2 Global TB Vaccine Treatment Revenue by Region: 2024-2029
3.4 North America TB Vaccine Treatment Market Facts & Figures by Country
3.4.1 North America TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America TB Vaccine Treatment Sales by Country (2018-2029)
3.4.3 North America TB Vaccine Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe TB Vaccine Treatment Market Facts & Figures by Country
3.5.1 Europe TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe TB Vaccine Treatment Sales by Country (2018-2029)
3.5.3 Europe TB Vaccine Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TB Vaccine Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific TB Vaccine Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific TB Vaccine Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America TB Vaccine Treatment Market Facts & Figures by Country
3.7.1 Latin America TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America TB Vaccine Treatment Sales by Country (2018-2029)
3.7.3 Latin America TB Vaccine Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa TB Vaccine Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa TB Vaccine Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa TB Vaccine Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global TB Vaccine Treatment Sales by Type (2018-2029)
4.1.1 Global TB Vaccine Treatment Sales by Type (2018-2023)
4.1.2 Global TB Vaccine Treatment Sales by Type (2024-2029)
4.1.3 Global TB Vaccine Treatment Sales Market Share by Type (2018-2029)
4.2 Global TB Vaccine Treatment Revenue by Type (2018-2029)
4.2.1 Global TB Vaccine Treatment Revenue by Type (2018-2023)
4.2.2 Global TB Vaccine Treatment Revenue by Type (2024-2029)
4.2.3 Global TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
4.3 Global TB Vaccine Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global TB Vaccine Treatment Sales by Application (2018-2029)
5.1.1 Global TB Vaccine Treatment Sales by Application (2018-2023)
5.1.2 Global TB Vaccine Treatment Sales by Application (2024-2029)
5.1.3 Global TB Vaccine Treatment Sales Market Share by Application (2018-2029)
5.2 Global TB Vaccine Treatment Revenue by Application (2018-2029)
5.2.1 Global TB Vaccine Treatment Revenue by Application (2018-2023)
5.2.2 Global TB Vaccine Treatment Revenue by Application (2024-2029)
5.2.3 Global TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
5.3 Global TB Vaccine Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck TB Vaccine Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Japan BCG Lab TB Vaccine Treatment Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India TB Vaccine Treatment Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AJ Vaccines TB Vaccine Treatment Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioFarma TB Vaccine Treatment Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GreenSignal Bio Pharma TB Vaccine Treatment Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotec TB Vaccine Treatment Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Biomed Lublin TB Vaccine Treatment Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Taj Pharmaceuticals TB Vaccine Treatment Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 TB Vaccine Treatment Industry Chain Analysis
7.2 TB Vaccine Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TB Vaccine Treatment Production Mode & Process
7.4 TB Vaccine Treatment Sales and Marketing
7.4.1 TB Vaccine Treatment Sales Channels
7.4.2 TB Vaccine Treatment Distributors
7.5 TB Vaccine Treatment Customers
8 TB VACCINE TREATMENT MARKET DYNAMICS
8.1 TB Vaccine Treatment Industry Trends
8.2 TB Vaccine Treatment Market Drivers
8.3 TB Vaccine Treatment Market Challenges
8.4 TB Vaccine Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of TB Vaccine Treatment
1.2 TB Vaccine Treatment Segment by Type
1.2.1 Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 TB Vaccine Treatment Segment by Application
1.3.1 Global TB Vaccine Treatment Market Value by Application: (2023-2029)
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global TB Vaccine Treatment Market Size Estimates and Forecasts
1.4.1 Global TB Vaccine Treatment Revenue 2018-2029
1.4.2 Global TB Vaccine Treatment Sales 2018-2029
1.4.3 Global TB Vaccine Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 TB VACCINE TREATMENT MARKET COMPETITION BY MANUFACTURERS
2.1 Global TB Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global TB Vaccine Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global TB Vaccine Treatment Average Price by Manufacturers (2018-2023)
2.4 Global TB Vaccine Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
2.7 TB Vaccine Treatment Market Competitive Situation and Trends
2.7.1 TB Vaccine Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest TB Vaccine Treatment Players Market Share by Revenue
2.7.3 Global TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 TB VACCINE TREATMENT RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global TB Vaccine Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global TB Vaccine Treatment Global TB Vaccine Treatment Sales by Region: 2018-2029
3.2.1 Global TB Vaccine Treatment Sales by Region: 2018-2023
3.2.2 Global TB Vaccine Treatment Sales by Region: 2024-2029
3.3 Global TB Vaccine Treatment Global TB Vaccine Treatment Revenue by Region: 2018-2029
3.3.1 Global TB Vaccine Treatment Revenue by Region: 2018-2023
3.3.2 Global TB Vaccine Treatment Revenue by Region: 2024-2029
3.4 North America TB Vaccine Treatment Market Facts & Figures by Country
3.4.1 North America TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America TB Vaccine Treatment Sales by Country (2018-2029)
3.4.3 North America TB Vaccine Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe TB Vaccine Treatment Market Facts & Figures by Country
3.5.1 Europe TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe TB Vaccine Treatment Sales by Country (2018-2029)
3.5.3 Europe TB Vaccine Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific TB Vaccine Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific TB Vaccine Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific TB Vaccine Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America TB Vaccine Treatment Market Facts & Figures by Country
3.7.1 Latin America TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America TB Vaccine Treatment Sales by Country (2018-2029)
3.7.3 Latin America TB Vaccine Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa TB Vaccine Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa TB Vaccine Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa TB Vaccine Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa TB Vaccine Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global TB Vaccine Treatment Sales by Type (2018-2029)
4.1.1 Global TB Vaccine Treatment Sales by Type (2018-2023)
4.1.2 Global TB Vaccine Treatment Sales by Type (2024-2029)
4.1.3 Global TB Vaccine Treatment Sales Market Share by Type (2018-2029)
4.2 Global TB Vaccine Treatment Revenue by Type (2018-2029)
4.2.1 Global TB Vaccine Treatment Revenue by Type (2018-2023)
4.2.2 Global TB Vaccine Treatment Revenue by Type (2024-2029)
4.2.3 Global TB Vaccine Treatment Revenue Market Share by Type (2018-2029)
4.3 Global TB Vaccine Treatment Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global TB Vaccine Treatment Sales by Application (2018-2029)
5.1.1 Global TB Vaccine Treatment Sales by Application (2018-2023)
5.1.2 Global TB Vaccine Treatment Sales by Application (2024-2029)
5.1.3 Global TB Vaccine Treatment Sales Market Share by Application (2018-2029)
5.2 Global TB Vaccine Treatment Revenue by Application (2018-2029)
5.2.1 Global TB Vaccine Treatment Revenue by Application (2018-2023)
5.2.2 Global TB Vaccine Treatment Revenue by Application (2024-2029)
5.2.3 Global TB Vaccine Treatment Revenue Market Share by Application (2018-2029)
5.3 Global TB Vaccine Treatment Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck TB Vaccine Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Japan BCG Lab
6.2.1 Japan BCG Lab Corporation Information
6.2.2 Japan BCG Lab Description and Business Overview
6.2.3 Japan BCG Lab TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Japan BCG Lab TB Vaccine Treatment Product Portfolio
6.2.5 Japan BCG Lab Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Serum Institute of India TB Vaccine Treatment Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 AJ Vaccines
6.4.1 AJ Vaccines Corporation Information
6.4.2 AJ Vaccines Description and Business Overview
6.4.3 AJ Vaccines TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AJ Vaccines TB Vaccine Treatment Product Portfolio
6.4.5 AJ Vaccines Recent Developments/Updates
6.5 BioFarma
6.5.1 BioFarma Corporation Information
6.5.2 BioFarma Description and Business Overview
6.5.3 BioFarma TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BioFarma TB Vaccine Treatment Product Portfolio
6.5.5 BioFarma Recent Developments/Updates
6.6 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GreenSignal Bio Pharma TB Vaccine Treatment Product Portfolio
6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
6.7 China National Biotec
6.6.1 China National Biotec Corporation Information
6.6.2 China National Biotec Description and Business Overview
6.6.3 China National Biotec TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 China National Biotec TB Vaccine Treatment Product Portfolio
6.7.5 China National Biotec Recent Developments/Updates
6.8 Biomed Lublin
6.8.1 Biomed Lublin Corporation Information
6.8.2 Biomed Lublin Description and Business Overview
6.8.3 Biomed Lublin TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Biomed Lublin TB Vaccine Treatment Product Portfolio
6.8.5 Biomed Lublin Recent Developments/Updates
6.9 Taj Pharmaceuticals
6.9.1 Taj Pharmaceuticals Corporation Information
6.9.2 Taj Pharmaceuticals Description and Business Overview
6.9.3 Taj Pharmaceuticals TB Vaccine Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Taj Pharmaceuticals TB Vaccine Treatment Product Portfolio
6.9.5 Taj Pharmaceuticals Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 TB Vaccine Treatment Industry Chain Analysis
7.2 TB Vaccine Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 TB Vaccine Treatment Production Mode & Process
7.4 TB Vaccine Treatment Sales and Marketing
7.4.1 TB Vaccine Treatment Sales Channels
7.4.2 TB Vaccine Treatment Distributors
7.5 TB Vaccine Treatment Customers
8 TB VACCINE TREATMENT MARKET DYNAMICS
8.1 TB Vaccine Treatment Industry Trends
8.2 TB Vaccine Treatment Market Drivers
8.3 TB Vaccine Treatment Market Challenges
8.4 TB Vaccine Treatment Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global TB Vaccine Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global TB Vaccine Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global TB Vaccine Treatment Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global TB Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global TB Vaccine Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global TB Vaccine Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market TB Vaccine Treatment Average Price (US$/K Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of TB Vaccine Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
Table 12. Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TB Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccine Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global TB Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 18. Global TB Vaccine Treatment Sales Market Share by Region (2018-2023)
Table 19. Global TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 20. Global TB Vaccine Treatment Sales Market Share by Region (2024-2029)
Table 21. Global TB Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global TB Vaccine Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global TB Vaccine Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 27. North America TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 28. North America TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 32. Europe TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 33. Europe TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific TB Vaccine Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific TB Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific TB Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global TB Vaccine Treatment Sales (K Dose) by Type (2018-2023)
Table 51. Global TB Vaccine Treatment Sales (K Dose) by Type (2024-2029)
Table 52. Global TB Vaccine Treatment Sales Market Share by Type (2018-2023)
Table 53. Global TB Vaccine Treatment Sales Market Share by Type (2024-2029)
Table 54. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global TB Vaccine Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global TB Vaccine Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2018-2023)
Table 59. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2024-2029)
Table 60. Global TB Vaccine Treatment Sales (K Dose) by Application (2018-2023)
Table 61. Global TB Vaccine Treatment Sales (K Dose) by Application (2024-2029)
Table 62. Global TB Vaccine Treatment Sales Market Share by Application (2018-2023)
Table 63. Global TB Vaccine Treatment Sales Market Share by Application (2024-2029)
Table 64. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global TB Vaccine Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global TB Vaccine Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2018-2023)
Table 69. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 73. Merck TB Vaccine Treatment Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Corporation Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 78. Japan BCG Lab TB Vaccine Treatment Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 83. Serum Institute of India TB Vaccine Treatment Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Corporation Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 88. AJ Vaccines TB Vaccine Treatment Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Corporation Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 93. BioFarma TB Vaccine Treatment Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Corporation Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 98. GreenSignal Bio Pharma TB Vaccine Treatment Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Corporation Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 103. China National Biotec TB Vaccine Treatment Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Corporation Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 108. Biomed Lublin TB Vaccine Treatment Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 113. Taj Pharmaceuticals TB Vaccine Treatment Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. TB Vaccine Treatment Distributors List
Table 118. TB Vaccine Treatment Customers List
Table 119. TB Vaccine Treatment Market Trends
Table 120. TB Vaccine Treatment Market Drivers
Table 121. TB Vaccine Treatment Market Challenges
Table 122. TB Vaccine Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global TB Vaccine Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global TB Vaccine Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global TB Vaccine Treatment Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global TB Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global TB Vaccine Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global TB Vaccine Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market TB Vaccine Treatment Average Price (US$/K Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of TB Vaccine Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of TB Vaccine Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of TB Vaccine Treatment, Product Type & Application
Table 12. Global Key Manufacturers of TB Vaccine Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TB Vaccine Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccine Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global TB Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 18. Global TB Vaccine Treatment Sales Market Share by Region (2018-2023)
Table 19. Global TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 20. Global TB Vaccine Treatment Sales Market Share by Region (2024-2029)
Table 21. Global TB Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global TB Vaccine Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global TB Vaccine Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 27. North America TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 28. North America TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 32. Europe TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 33. Europe TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific TB Vaccine Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific TB Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific TB Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific TB Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific TB Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa TB Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa TB Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa TB Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa TB Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa TB Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global TB Vaccine Treatment Sales (K Dose) by Type (2018-2023)
Table 51. Global TB Vaccine Treatment Sales (K Dose) by Type (2024-2029)
Table 52. Global TB Vaccine Treatment Sales Market Share by Type (2018-2023)
Table 53. Global TB Vaccine Treatment Sales Market Share by Type (2024-2029)
Table 54. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global TB Vaccine Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global TB Vaccine Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global TB Vaccine Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2018-2023)
Table 59. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2024-2029)
Table 60. Global TB Vaccine Treatment Sales (K Dose) by Application (2018-2023)
Table 61. Global TB Vaccine Treatment Sales (K Dose) by Application (2024-2029)
Table 62. Global TB Vaccine Treatment Sales Market Share by Application (2018-2023)
Table 63. Global TB Vaccine Treatment Sales Market Share by Application (2024-2029)
Table 64. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global TB Vaccine Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global TB Vaccine Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global TB Vaccine Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2018-2023)
Table 69. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 73. Merck TB Vaccine Treatment Product
Table 74. Merck Recent Developments/Updates
Table 75. Japan BCG Lab Corporation Information
Table 76. Japan BCG Lab Description and Business Overview
Table 77. Japan BCG Lab TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 78. Japan BCG Lab TB Vaccine Treatment Product
Table 79. Japan BCG Lab Recent Developments/Updates
Table 80. Serum Institute of India Corporation Information
Table 81. Serum Institute of India Description and Business Overview
Table 82. Serum Institute of India TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 83. Serum Institute of India TB Vaccine Treatment Product
Table 84. Serum Institute of India Recent Developments/Updates
Table 85. AJ Vaccines Corporation Information
Table 86. AJ Vaccines Description and Business Overview
Table 87. AJ Vaccines TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 88. AJ Vaccines TB Vaccine Treatment Product
Table 89. AJ Vaccines Recent Developments/Updates
Table 90. BioFarma Corporation Information
Table 91. BioFarma Description and Business Overview
Table 92. BioFarma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 93. BioFarma TB Vaccine Treatment Product
Table 94. BioFarma Recent Developments/Updates
Table 95. GreenSignal Bio Pharma Corporation Information
Table 96. GreenSignal Bio Pharma Description and Business Overview
Table 97. GreenSignal Bio Pharma TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 98. GreenSignal Bio Pharma TB Vaccine Treatment Product
Table 99. GreenSignal Bio Pharma Recent Developments/Updates
Table 100. China National Biotec Corporation Information
Table 101. China National Biotec Description and Business Overview
Table 102. China National Biotec TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 103. China National Biotec TB Vaccine Treatment Product
Table 104. China National Biotec Recent Developments/Updates
Table 105. Biomed Lublin Corporation Information
Table 106. Biomed Lublin Description and Business Overview
Table 107. Biomed Lublin TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 108. Biomed Lublin TB Vaccine Treatment Product
Table 109. Biomed Lublin Recent Developments/Updates
Table 110. Taj Pharmaceuticals Corporation Information
Table 111. Taj Pharmaceuticals Description and Business Overview
Table 112. Taj Pharmaceuticals TB Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (US$/K Dose) and Gross Margin (2018-2023)
Table 113. Taj Pharmaceuticals TB Vaccine Treatment Product
Table 114. Taj Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. TB Vaccine Treatment Distributors List
Table 118. TB Vaccine Treatment Customers List
Table 119. TB Vaccine Treatment Market Trends
Table 120. TB Vaccine Treatment Market Drivers
Table 121. TB Vaccine Treatment Market Challenges
Table 122. TB Vaccine Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of TB Vaccine Treatment
Figure 2. Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global TB Vaccine Treatment Market Share by Type in 2022 & 2029
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global TB Vaccine Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global TB Vaccine Treatment Market Share by Application in 2022 & 2029
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global TB Vaccine Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global TB Vaccine Treatment Market Size (2018-2029) & (US$ Million)
Figure 13. Global TB Vaccine Treatment Sales (2018-2029) & (K Dose)
Figure 14. Global TB Vaccine Treatment Average Price (US$/K Dose) & (2018-2029)
Figure 15. TB Vaccine Treatment Report Years Considered
Figure 16. TB Vaccine Treatment Sales Share by Manufacturers in 2022
Figure 17. Global TB Vaccine Treatment Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest TB Vaccine Treatment Players: Market Share by Revenue in 2022
Figure 19. TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 22. North America TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 23. United States TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 26. Europe TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 27. Germany TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific TB Vaccine Treatment Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific TB Vaccine Treatment Revenue Market Share by Region (2018-2029)
Figure 34. China TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 44. Latin America TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 45. Mexico TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 50. Turkey TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of TB Vaccine Treatment by Type (2018-2029)
Figure 54. Global Revenue Market Share of TB Vaccine Treatment by Type (2018-2029)
Figure 55. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2018-2029)
Figure 56. Global Sales Market Share of TB Vaccine Treatment by Application (2018-2029)
Figure 57. Global Revenue Market Share of TB Vaccine Treatment by Application (2018-2029)
Figure 58. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2018-2029)
Figure 59. TB Vaccine Treatment Value Chain
Figure 60. TB Vaccine Treatment Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Product Picture of TB Vaccine Treatment
Figure 2. Global TB Vaccine Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global TB Vaccine Treatment Market Share by Type in 2022 & 2029
Figure 4. Immune Vaccine Product Picture
Figure 5. Therapy Vaccine Product Picture
Figure 6. Global TB Vaccine Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global TB Vaccine Treatment Market Share by Application in 2022 & 2029
Figure 8. Self-Procurement
Figure 9. UNICEF
Figure 10. Other
Figure 11. Global TB Vaccine Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global TB Vaccine Treatment Market Size (2018-2029) & (US$ Million)
Figure 13. Global TB Vaccine Treatment Sales (2018-2029) & (K Dose)
Figure 14. Global TB Vaccine Treatment Average Price (US$/K Dose) & (2018-2029)
Figure 15. TB Vaccine Treatment Report Years Considered
Figure 16. TB Vaccine Treatment Sales Share by Manufacturers in 2022
Figure 17. Global TB Vaccine Treatment Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest TB Vaccine Treatment Players: Market Share by Revenue in 2022
Figure 19. TB Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global TB Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 22. North America TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 23. United States TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 26. Europe TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 27. Germany TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific TB Vaccine Treatment Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific TB Vaccine Treatment Revenue Market Share by Region (2018-2029)
Figure 34. China TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 44. Latin America TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 45. Mexico TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa TB Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa TB Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 50. Turkey TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE TB Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of TB Vaccine Treatment by Type (2018-2029)
Figure 54. Global Revenue Market Share of TB Vaccine Treatment by Type (2018-2029)
Figure 55. Global TB Vaccine Treatment Price (US$/K Dose) by Type (2018-2029)
Figure 56. Global Sales Market Share of TB Vaccine Treatment by Application (2018-2029)
Figure 57. Global Revenue Market Share of TB Vaccine Treatment by Application (2018-2029)
Figure 58. Global TB Vaccine Treatment Price (US$/K Dose) by Application (2018-2029)
Figure 59. TB Vaccine Treatment Value Chain
Figure 60. TB Vaccine Treatment Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
